No abstract available
Publication types
-
Case Reports
-
Letter
-
Research Support, N.I.H., Extramural
MeSH terms
-
Antineoplastic Agents / therapeutic use*
-
Biopsy
-
Carcinoma, Renal Cell / drug therapy*
-
Carcinoma, Renal Cell / enzymology
-
Carcinoma, Renal Cell / genetics
-
Carcinoma, Renal Cell / pathology
-
Crizotinib
-
Disease Progression
-
Drug Substitution*
-
Humans
-
Immunohistochemistry
-
Kidney Neoplasms / drug therapy*
-
Kidney Neoplasms / enzymology
-
Kidney Neoplasms / genetics
-
Kidney Neoplasms / pathology
-
Male
-
Middle Aged
-
Mutation*
-
Protein Kinase Inhibitors / therapeutic use*
-
Proto-Oncogene Proteins c-met / antagonists & inhibitors*
-
Proto-Oncogene Proteins c-met / genetics*
-
Proto-Oncogene Proteins c-met / metabolism
-
Pyrazoles / therapeutic use*
-
Pyridines / therapeutic use*
-
Pyrrolidinones / therapeutic use*
-
Quinolines / therapeutic use*
-
Time Factors
-
Tomography, X-Ray Computed
-
Treatment Outcome
Substances
-
ARQ 197
-
Antineoplastic Agents
-
Protein Kinase Inhibitors
-
Pyrazoles
-
Pyridines
-
Pyrrolidinones
-
Quinolines
-
Crizotinib
-
MET protein, human
-
Proto-Oncogene Proteins c-met
Supplementary concepts
-
Papillary renal cell carcinoma, sporadic